Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ptc Therapeutics (NQ: PTCT ) 43.18 +2.31 (+5.65%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Ptc Therapeutics < Previous 1 2 3 4 5 6 Next > PTC Therapeutics's Return On Capital Employed Insights May 04, 2023 Via Benzinga Why did Sarepta Therapeutics Stock Plummet? March 21, 2023 SRPT stock fell 20% after the FDA changed course on their new DMD treatment approval. The stock remains strong with an encouraging outlook and a mod Buy rating. Via MarketBeat Exposures Product Safety Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023 March 17, 2023 Via Benzinga Looking Into PTC Therapeutics's Return On Capital Employed February 22, 2023 Via Benzinga Earnings Outlook For PTC Therapeutics February 20, 2023 Via Benzinga Expert Ratings for PTC Therapeutics December 14, 2022 Via Benzinga PTC Therapeutics Gets $1B Funding From Blackstone, Shares Fall October 28, 2022 Via Benzinga Earnings Scheduled For April 27, 2023 April 27, 2023 Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its first quarter. Via Benzinga Analyst Expectations for PTC Therapeutics's Future April 18, 2023 Via Benzinga Where PTC Therapeutics Stands With Analysts March 17, 2023 Via Benzinga Reaction Is Overdone For PTC Therapeutics Pausing Huntington Trial Enrollment, Analyst Says October 19, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 December 14, 2022 Via Benzinga PTC Therapeutics Pauses Enrollment In Huntington's Candidate Trial In US October 19, 2022 Via Benzinga What 5 Analyst Ratings Have To Say About PTC Therapeutics October 17, 2022 Within the last quarter, PTC Therapeutics (NASDAQ:PTCT) has observed the following analyst ratings: Via Benzinga 7 Nasdaq Stocks to Sell Before They Plunge in 2023 December 05, 2022 While loyalty may be a positive trait in most circumstances, when it comes to Nasdaq stocks to sell, you got to look out for number one. Via InvestorPlace PTC Therapeutics's Return On Capital Employed Overview November 02, 2022 According to Benzinga Pro data, during Q3, PTC Therapeutics (NASDAQ:PTCT) posted sales of $217.13 million. Earnings were up 28.12%, but PTC Therapeutics still reported an overall loss of $109.31... Via Benzinga Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday October 31, 2022 Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday. Via Benzinga Expert Ratings for PTC Therapeutics October 17, 2022 Analysts have provided the following ratings for PTC Therapeutics (NASDAQ:PTCT) within the last quarter: Via Benzinga Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session October 28, 2022 Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) surged 179% to $3.6301. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session October 28, 2022 Gainers Nuvalent (NASDAQ:NUVL) stock increased by 15.9% to $25.5 during Friday's pre-market session. The company's market cap stands at $1.2 billion. Via Benzinga Analyst Ratings for PTC Therapeutics October 17, 2022 Within the last quarter, PTC Therapeutics (NASDAQ:PTCT) has observed the following analyst ratings: Via Benzinga Analyst Ratings for PTC Therapeutics September 09, 2022 Analysts have provided the following ratings for PTC Therapeutics (NASDAQ:PTCT) within the last quarter: Via Benzinga Earnings Scheduled For October 27, 2022 October 27, 2022 Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session October 19, 2022 Gainers Kintara Therapeutics (NASDAQ:KTRA) shares moved upwards by 74.8% to $0.17 during Wednesday's pre-market session. The company's market cap stands at $14.1 million. Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session October 18, 2022 Gainers Via Benzinga Marten Transport, Silvergate Capital And Some Other Big Stocks Moving Lower On Tuesday October 18, 2022 U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Tuesday. Here are some big stocks recording losses in today’s session. Via Benzinga Roche's Muscular Atrophy Treatment Improves Motor Function In Pretreated Patients October 12, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2022 September 12, 2022 Upgrades Via Benzinga Newman Ferrara LLP Announces Corporate Governance Investigations of PTC Therapeutics (PTCT) September 07, 2022 From Newman Ferrara LLP Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022 September 09, 2022 Upgrades Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
